Close

Brean Capital Starts MEI Pharma (MEIP) at Buy, PT $16

January 10, 2014 8:48 AM EST Send to a Friend
Brean Capital initiated coverage on MEI Pharma (NASDAQ: MEIP) with a Buy rating and price target of $16.00.

Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login